Analyze Diet
Journal of veterinary internal medicine2026; 40(5); aalag187; doi: 10.1093/jvimsj/aalag187

Randomized study of the effects of testosterone administration on severity of asthma in horses.

Abstract: Low testosterone concentrations are associated with poor lung function in human asthmatics, and androgen administration improves airway obstruction in women with asthma. Objective: Testosterone improves clinical scores, lung function, airway neutrophilia, and airway remodeling in horses with severe asthma. Methods: Ten horses affected by severe asthma from a research herd. Methods: In a randomized, blinded, crossover study, horses received dexamethasone (0.06 mg/kg PO q24h for 10 days) or a single intramuscular injection of testosterone cypionate (0.35 mg/kg), with a 2-week washout period. Clinical respiratory scores were assessed at days 0, 2, 5, and 10; lung function was evaluated at days 0, 5, and 10; and bronchoalveolar lavage fluid cytology and central airway remodeling at days 0 and 10. Mixed linear models were used for analysis. Results: The respiratory clinical scores improved with dexamethasone administration (median [95% CI], from 12 (9-13) to 5 (3-6), P < .001), and remained unchanged with testosterone administration (from 10 [8-12] to 9 [8-11], P = .6). Pulmonary elastance improved with both treatments, but the effect was more pronounced with dexamethasone administration (from 5.1 cm H2O/L [2.4-5.8] to 0.5 [0.4-0.8], P < .001) than with testosterone administration (from 4.5 cm H2O/L [1.6-8.5] to 3.0 [1.0-4.1], P = .04). Pleural pressure and pulmonary resistance decreased only with dexamethasone. Neither treatment altered airway neutrophilia or bronchial remodeling. Conclusions: Testosterone is less effective than dexamethasone and only mildly improves pulmonary elastance in horses with severe asthma.
Publication Date: 2026-09-06 PubMed ID: 42702362DOI: 10.1093/jvimsj/aalag187Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Randomized Controlled Trial

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigated whether administering testosterone affects the severity of severe asthma in horses, comparing its effects to those of dexamethasone, a known asthma treatment.
  • The results showed that testosterone mildly improved lung function but was not as effective as dexamethasone in reducing symptoms or airway inflammation in horses with severe asthma.

Background and Objective

  • Previous human studies indicated low testosterone is linked to poorer lung function in asthmatics.
  • Androgen (testosterone) treatments helped improve airway obstruction in women with asthma.
  • This study aimed to evaluate if testosterone improves clinical signs, lung function, airway neutrophilia (a type of airway inflammation), and remodeling in horses diagnosed with severe asthma.

Study Design and Methods

  • Subjects: 10 horses all affected by severe asthma, taken from a research herd.
  • Study Type: Randomized, blinded, crossover study where each horse served as its own control.
  • Treatments:
    • Dexamethasone (a corticosteroid) administered orally at 0.06 mg/kg once daily for 10 days.
    • Testosterone cypionate given as a single intramuscular injection at 0.35 mg/kg.
  • Washout period of 2 weeks between treatments to avoid carryover effects.
  • Assessments:
    • Clinical respiratory scores measured on days 0, 2, 5, and 10 to track symptoms.
    • Lung function tests conducted on days 0, 5, and 10 focusing on parameters like pulmonary elastance, pleural pressure, and pulmonary resistance.
    • Bronchoalveolar lavage fluid (BALF) cytology and airway remodeling evaluated on days 0 and 10.
  • Data analysis used mixed linear models appropriate for crossover studies.

Key Findings

  • Clinical Scores:
    • Dexamethasone significantly improved respiratory clinical scores (median score decreased from 12 to 5; P < .001).
    • Testosterone administration did not significantly change clinical scores (10 to 9; P = .6).
  • Lung Function – Pulmonary Elastance:
    • Elastance measures lung stiffness; lower values indicate improvement.
    • Both treatments improved pulmonary elastance, but dexamethasone showed a much stronger effect (from 5.1 to 0.5) compared to testosterone (4.5 to 3.0).
  • Pleural Pressure and Pulmonary Resistance:
    • Only dexamethasone decreased pleural pressure and pulmonary resistance, measures related to airflow and ease of breathing.
  • Airway Neutrophilia and Remodeling:
    • Neither treatment changed the number of neutrophils (airway inflammation) or the degree of airway structural remodeling after treatment.

Conclusions and Implications

  • Testosterone administration led to mild improvement in lung mechanics but did not significantly reduce clinical signs of asthma in horses.
  • Dexamethasone was more effective in improving symptoms, lung function, and airway mechanics.
  • Neither treatment was effective in reducing airway inflammation (neutrophilia) or structural remodeling in the short term.
  • The findings indicate while testosterone has some positive effects on lung function, it cannot replace corticosteroids for treating severe equine asthma.
  • These results contribute to understanding hormonal influence on asthma but suggest testosterone alone is insufficient as a treatment.

Cite This Article

APA
Ruault C, Mainguy-Seers S, Leduc L, Juette T, St-Jean G, Lavoie JP. (2026). Randomized study of the effects of testosterone administration on severity of asthma in horses. J Vet Intern Med, 40(5), aalag187. https://doi.org/10.1093/jvimsj/aalag187

Publication

ISSN: 1939-1676
NlmUniqueID: 8708660
Country: England
Language: English
Volume: 40
Issue: 5
PII: aalag187

Researcher Affiliations

Ruault, Camille
  • Department of Clinical Sciences, Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, Quebec, Canada.
Mainguy-Seers, Sophie
  • Department of Clinical Sciences, Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, Quebec, Canada.
Leduc, Laurence
  • Department of Clinical Sciences, Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, Quebec, Canada.
Juette, Tristan
  • Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, Quebec, Canada.
St-Jean, Guillaume
  • Department of Pathology and Microbiology, Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, Quebec, Canada.
Lavoie, Jean-Pierre
  • Department of Clinical Sciences, Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, Quebec, Canada.

MeSH Terms

  • Animals
  • Horses
  • Asthma / veterinary
  • Asthma / drug therapy
  • Horse Diseases / drug therapy
  • Testosterone / analogs & derivatives
  • Testosterone / therapeutic use
  • Testosterone / administration & dosage
  • Female
  • Cross-Over Studies
  • Dexamethasone / therapeutic use
  • Male
  • Bronchoalveolar Lavage Fluid / cytology
  • Injections, Intramuscular / veterinary
  • Airway Remodeling / drug effects

Citations

This article has been cited 0 times.